2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Immuno-oncology represents the cutting edge of modern cancer treatment. For the first time, it provides unprecedented ways of activating the body's immune system against tumors. Newer technologies such as checkpoint inhibitors, bispecific antibodies, and engineered immune cells are turning once-fatal cancers into manageable or even curable diseases. Recent advances in understanding tumor-immune interaction and the tumor microenvironment have led to the development of next-generation immunotherapies with greater precision and durability. Artificial intelligence combined with biomarker-driven research is further improving the selection of patients likely to benefit and predicting their response, thus moving toward personalized immunotherapy.

This session at the Cancer Research and Development Conference 2026 will discuss recent discoveries and clinical advances in immuno-oncology, presented by leading experts in the field. Discussion topics will include novel therapeutic platforms, combination strategies, and overcoming immune resistance. We invite you to join our session as innovation continuously paves new paths into the future of cancer immunotherapy: more effective, targeted, and longer-lasting treatments for patients across the world.